Description
The Erythropoietin IU Injection is a specialized hematopoietic agent designed for healthcare professionals to manage anemia due to chronic kidney disease (CKD) and other medical conditions such as cancer treatment.
- Key Features: Hematopoietic Agent: Contains recombinant erythropoietin, a glycoproteinthat addresses erythropoiesis deficiency.
- Therapeutic Performance: Clinically formulated to increase red blood cellcount, enhancing oxygen transportation.
- Sterile Injectable Solution: Each unit is pre-measured and sterile, ensuring precision and safety in administration.
- Patient-Centric: Tailored for individual treatment plans depending onpatient-specific needs and responses.
- Benefits: Improves Quality of Life: Enhances patient vitality and reduces symptomsof chronic anemia.
- Versatile Applications: Effective for a broad range of conditions, including anemia in CKD, cancer, and HIV patients.
- Customizable Dosage: Can be adjusted based on hemoglobin levels andpatient response to therapy.
- Usage Recommendations: Administer under the guidance of a qualified healthcare professional asprescribed.
